Psychotropic drug consumption and compliance

被引:1
作者
Baumann, M [1 ]
Baumann, C [1 ]
Alla, F [1 ]
机构
[1] Univ Nancy 1, Fac Med, Ecole Sante Publ, EA 3444, F-54505 Vandoeuvre Les Nancy, France
来源
PRESSE MEDICALE | 2004年 / 33卷 / 07期
关键词
D O I
10.1016/S0755-4982(04)98627-7
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective To differentiate, over a 5-year period, non-compliant (NC) from compliant (C) consumers of psychotropic drugs according to their demographic caracteristics and views on: their faith in the prescriber, the effects of consumption, opinion of family and friends and information received. Method Among 166 consumers (mean age 55 yrs), two questions for each psychotropic drug consumed for 5 years classified them as NC or C. Data were collected by auto-assessments and telephone interviews. Results Thirty-nine percent of consumers were defined as NC. The majority of psychotropic drugs were prescribed by general practitioners, whose patients were less compliant than psychiatrist's patients. The NC were more inclined to feel positive effects after taking the drug and stated they could do without it. Ninety percent of consumers had a positive attitude to psychotropes and 40% spoke about their consumption to friends and family notably among the NC. Only 12% of consumers do not seek information on psychotropic drugs because they trusted their prescriber. Discussion Psychotropic drug consumers require therapeutic education better adapted to their expectations.
引用
收藏
页码:445 / 448
页数:4
相关论文
共 14 条
[1]
5-year trajectory and dependence on psychotropic drugs of a users' cohort [J].
Alla, F ;
Baumann, M .
THERAPIE, 2003, 58 (02) :145-151
[2]
BAUDIER F, 1994, BAROMETRE SANTE 92 E
[3]
Baumann M, 2002, ENCEPHALE, V28, P389
[4]
Bergmann JF, 2002, THERAPIE, V57, P366
[5]
DETECTION METHODS AND STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE [J].
BOND, WS ;
HUSSAR, DA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (09) :1978-1988
[6]
GUEFFI JD, 1998, PRESSE MED, V27, P2126
[7]
A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study - Design, methods, and participant characteristics [J].
Hercberg, S ;
Preziosi, P ;
Briancon, S ;
Galan, P ;
Triol, I ;
Malvy, D ;
Roussel, AM ;
Favier, A .
CONTROLLED CLINICAL TRIALS, 1998, 19 (04) :336-351
[8]
Measuring patients' expectations and requests [J].
Kravitz, RL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) :881-888
[9]
Legrain Marcel, 1998, Annales Pharmaceutiques Francaises, V56, P67
[10]
Organisation Mondiale de la Sante, 1998, ED THER PAT PROGR FO